EDSA
EDSA
NASDAQ · Biotechnology

Edesa Biotech Inc

$5.82
-0.04 (-0.68%)
Financial Highlights (FY 2025)
Revenue
2.48M
Net Income
-380,025
Gross Margin
38.1%
Profit Margin
-15.3%
Rev Growth
+22.9%
D/E Ratio
0.29
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 38.1% 38.1% 38.1%
Operating Margin -18.9% -21.9% -17.8%
Profit Margin -15.3% -18.8% -17.2%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.48M 2.49M 2.71M
Gross Profit 943.6K 949.8K 1.03M
Operating Income -467,600 -546,543 -483,815
Net Income -380,025 -467,867 -467,071
Gross Margin 38.1% 38.1% 38.1%
Operating Margin -18.9% -21.9% -17.8%
Profit Margin -15.3% -18.8% -17.2%
Rev Growth +22.9% +23.1% -7.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 990.1K 775.0K 843.9K
Total Equity 3.39M 3.01M 3.06M
D/E Ratio 0.29 0.26 0.28
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -552,767 -558,041 -685,415
Free Cash Flow -221,579 -328,689 -323,480